Molecular
Molecular testing utilizes polymerase chain reaction (PCR) technology to detect and confirm the presence of infectious diseases such as COVID-19. Bluewater implements PCR technology to determine whether a patient’s sample contains genetic material from a particular pathogen. PCR molecular identification is considered the gold standard in detecting pathogens like SARS-CoV-2. Detection of a pathogen can occur within days of exposure to the infection, even when individuals are asymptomatic.
Turnaround time for a PCR test is typically longer, averaging around two to three days, based on testing demands. It is encouraged to obtain a confirmation test via PCR molecular identification for individuals experiencing COVID-19 symptoms, or individuals with a high risk of exposure.
Bluewater Dx provides several molecular-based testing solutions for our healthcare partners:
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Trichomonas vaginalis
- SARS-CoV-2 (COVID-19)
- Hepatitis C Viral Load Confirmation
- QuantiFERON-TB Gold Plus